Doctor profile · Federal record

Dr. Tara Linville, PA-C

Medical Physician Assistant (CMS: Physician Assistant) · Tulsa, OK

  • NPI 1013994458
  • Accepts Medicare
  • MIPS 93.3 / 100 · 2023
  • 26 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
6565 S Yale Ave Ste 1200
Tulsa, OK 74136
(918) 502-3376
fax (918) 502-3375
Additional location
501 Se Frank Phillips Blvd, Suite 202
Bartlesville, OK 740033913
(918) 336-5454
fax (918) 336-4449
Mailing address
6600 S Yale Ave Ste 1200
Tulsa, OK 741363361

Credentials & registration

NPPES · NUCC
NPI registered
December 2005 — 21 yrs on file
Profile last updated
May 14, 2018
Year of graduation
2000 — 26 yrs since
Specialty taxonomy
363AM0700X — NUCC code
State license (1)
Oklahoma #1108
Medicaid
OK #200060190A

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1013994458. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
3,102
Distinct HCPCS
10
Medicare allowed
$176,621
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 1,084 174 $5
99213 Established patient office or other outpatient visit, 20-29 minutes 660 460 $72
17110 Destruction of skin growth, 1-14 growths 325 271 $87
17000 Destruction of precancer skin growth, 1 growth 279 226 $42
99203 New patient office or other outpatient visit, 30-44 minutes 221 221 $89
99214 Established patient office or other outpatient visit, 30-39 minutes 172 121 $102
11102 Biopsy of related skin growth, first growth 107 102 $70
17111 Destruction of skin growth, 15 or more growths 67 54 $103
99204 New patient office or other outpatient visit, 45-59 minutes 54 54 $134
17004 Destruction of precancer skin growth, 15 or more growths 33 23 $133

In context: peer comparison

Among 21 peers in this city , average services per provider: 78. This provider delivers 40× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$5,006
Transactions
231
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
E.R. Squibb & Sons, L.L.C. 31 $670.18
ABBVIE INC. 31 $660.83
Janssen Biotech, Inc. 20 $562.16
Regeneron Healthcare Solutions, Inc. 17 $509.90
Lilly USA, LLC 27 $466.80
Arcutis Biotherapeutics, Inc. 22 $390.65
Novartis Pharmaceuticals Corporation 16 $331.20
Amgen Inc. 11 $284.01
PFIZER INC. 11 $252.74
UCB, Inc. 10 $221.21
Ortho Dermatologics, a division of Bausch Health US, LLC 10 $179.09
Dermavant Sciences, Inc. 12 $172.37
SUN PHARMACEUTICAL INDUSTRIES INC. 8 $165.88
Galderma Laboratories, L.P. 3 $48.78
LEO Pharma Inc. 2 $30.91

By nature of payment

Food and Beverage
$4,812
Education
$195

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,008
Patients
588
Total drug cost
$29,937
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 195 135 $3,797
Ketoconazole Generic 167 92 $3,225
Doxycycline Hyclate Generic 84 49 $1,773
Hydrocortisone Generic 82 56 $539
Betamethasone Dipropionate Generic 79 50 $6,308
Clobetasol Propionate Generic 72 34 $3,406
Minocycline Hcl Generic 52 33 $1,758
Doxepin Hcl Generic 48 19 $755
Hydroxyzine Hcl Generic 38 16 $379
Fluocinonide Generic 37 26 $2,953

Frequently asked questions

Auto-generated from federal data
What is Dr. Tara Linville's medical specialty?
Dr. Tara Linville practices Medical Physician Assistant in Tulsa, OK.
Where does Dr. Tara Linville practice?
Dr. Tara Linville practices at 6565 S Yale Ave Ste 1200, Tulsa, OK 74136. Office phone: 9185023376.
What is Dr. Tara Linville's NPI?
Dr. Tara Linville's National Provider Identifier (NPI) is 1013994458, issued by NPPES.
Does Dr. Tara Linville accept Medicare assignment?
Yes. Dr. Tara Linville accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Tara Linville commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of skin growth, 1-14 growths (HCPCS 17110). Source: CMS Medicare Physician & Other Practitioners file.